Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Net Income: 2019-2024

Historic Net Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to -$87.9 million.

  • Mirum Pharmaceuticals' Net Income rose 120.41% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.4 million, marking a year-over-year increase of 58.50%. This contributed to the annual value of -$87.9 million for FY2024, which is 46.18% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Net Income of -$87.9 million as of FY2024, which was up 46.18% from -$163.4 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Net Income peaked at -$84.3 million during FY2021, and registered a low of -$163.4 million during FY2023.
  • Its 3-year average for Net Income is -$129.0 million, with a median of -$135.7 million in 2022.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Net Income slumped by 96.25% in 2020 and then spiked by 46.18% in 2024.
  • Mirum Pharmaceuticals' Net Income (Yearly) stood at -$103.4 million in 2020, then climbed by 18.50% to -$84.3 million in 2021, then tumbled by 61.02% to -$135.7 million in 2022, then declined by 20.45% to -$163.4 million in 2023, then skyrocketed by 46.18% to -$87.9 million in 2024.